An open-label, randomized phase III trial has been established to compare the efficacy and safety profile of tegafur and uracil (UFT) plus leucovorin with fluorouracil (5-FU) plus leucovorin as first-line chemotherapy for
James Carmichael, BSc, MBChB, MD, FRCP
Advertisement
Articles by James Carmichael, BSc, MBChB, MD, FRCP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
2
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
3
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
4
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
5